Novel mechanism of regulation of the non-receptor protein tyrosine kinase Csk: Insights from NMR mapping studies and site-directed mutagenesis

被引:30
作者
Shekhtman, A
Ghose, R
Wang, DX
Cole, PA
Cowburn, D
机构
[1] Rockefeller Univ, New York, NY 10021 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA
[3] New York Struct Biol Ctr, New York, NY 10021 USA
关键词
protein tyrosine kinase; SH3; domain; Src-family kinases; heteronuclear NMR;
D O I
10.1006/jmbi.2001.5126
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Csk (C-terminal Src kinase), a protein tyrosine kinase, consisting of the Src homology 2 and 3 (SH2 and SH3) domains and a catalytic domain, phosphorylates the C-terminal tail of Src-family members, resulting in downregulation of the Src family kinase activity. The Src family kinases share 37% homology with Csk but, unlike Src-family kinases, the catalytic domain of Csk alone is weakly active and can be stimulated in trans by interacting with the Csk-SH3 domain, suggesting a mode of intradomain regulation different from that of Src family kinases. The structural determinants of this intermolecular interaction were studied by nuclear magnetic resonance (NMR) and site-directed mutagenesis techniques. Chemical shift perturbation of backbone nuclei (H' and N-15) has been used to map the Csk catalytic domain binding site on the Csk-SH3. The experimentally determined interaction surface includes three structural elements: th N-terminal tail, a small part of the RT-loop, and the C-terminal SH3-SH2 linker. Site-directed mutagenesis revealed that mutations in the SH3-SH2 linker of the wild-type Csk decrease Csk kinase activity up to fivefold, whereas mutations in the RT-loop left Csk kinase activity largely unaffected. We conclude that the SH3-SH2 linker plays a major role in the activation of the Csk catalytic domain. (C) 2001 Academic Press.
引用
收藏
页码:129 / 138
页数:10
相关论文
共 41 条
[1]  
AIZAWA S, 1994, MOLECULAR AND CELLULAR BASIS FOR CELL TO CELL INTERACTION: ITS SIGNIFICANCE IN CANCER, P323
[2]  
Bénistant C, 2001, CANCER RES, V61, P1415
[3]   THE CRYSTAL-STRUCTURE OF HUMAN CSKSH3 - STRUCTURAL DIVERSITY NEAR THE RT-SRC AND N-SRC LOOP [J].
BORCHERT, TV ;
MATHIEU, M ;
ZEELEN, JP ;
COURTNEIDGE, SA ;
WIERENGA, RK .
FEBS LETTERS, 1994, 341 (01) :79-85
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   ISOLATION AND CHARACTERIZATION OF A HUMAN GENE THAT ENCODES A NEW SUBCLASS OF PROTEIN TYROSINE KINASES [J].
BRAUNINGER, A ;
HOLTRICH, U ;
STREBHARDT, K ;
RUBSAMENWAIGMANN, H .
GENE, 1992, 110 (02) :205-211
[6]   Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase Csk and is involved in regulation of T cell activation [J].
Brdicka, T ;
Pavilstová, D ;
Leo, A ;
Bruyns, E ;
Korínek, V ;
Angelisová, P ;
Scherer, J ;
Shevchenko, A ;
Shevchenko, A ;
Hilgert, I ;
Cerny, J ;
Drbal, K ;
Kuramitsu, Y ;
Kornacker, B ;
Horejsí, V ;
Schraven, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (09) :1591-1604
[7]   NEGATIVE REGULATION OF T-CELL RECEPTOR SIGNALING BY TYROSINE PROTEIN-KINASE P50(CSK) [J].
CHOW, LML ;
FOURNEL, M ;
DAVIDSON, D ;
VEILLETTE, A .
NATURE, 1993, 365 (6442) :156-160
[8]   Association of inhibitory tyrosine protein kinase p50(csk) with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells [J].
Cloutier, JF ;
Veillette, A .
EMBO JOURNAL, 1996, 15 (18) :4909-4918
[9]  
CLOUTIER JF, 1995, MOL CELL BIOL, V15, P5937
[10]   NMRPIPE - A MULTIDIMENSIONAL SPECTRAL PROCESSING SYSTEM BASED ON UNIX PIPES [J].
DELAGLIO, F ;
GRZESIEK, S ;
VUISTER, GW ;
ZHU, G ;
PFEIFER, J ;
BAX, A .
JOURNAL OF BIOMOLECULAR NMR, 1995, 6 (03) :277-293